机构：[1]Department of Hematology, Xuanwu Hospital, Capital Medical University, China.E-mail:, Beijing, 100053, China内科系统血液科首都医科大学宣武医院
出处：
ISSN：
摘要：
We treated 4 with a diagnosis of diffuse large B cell lymphoma involving the gastrointestinal tract with rituximab combined with adjusted dose EPOCH (R-DA-EPOCH) scheme based on a comprehensive analysis of the onset process, clinical and pathological features, and prognosis of the patients, and evaluated their treatment response. Complete remission (CR) was achieved in 3 patients after the treatment and 1 patient with diabetes and hypertension died due to severe infection. R-DA-EPOCH regimen as the first-line treatment of gastrointestinal diffuse large B cell lymphoma has a good short-term efficacy, but its long-term efficacy awaits further evaluation in future studies with larger sample sizes.
语种：
外文
第一作者：
第一作者机构：[1]Department of Hematology, Xuanwu Hospital, Capital Medical University, China.E-mail:, Beijing, 100053, China
推荐引用方式(GB/T 7714)：
Hu R.-H,Sun W.-L,Zhao H,et al.Rituximab combined with EPOCH regimen for treatment of diffuse large B cell lymphoma of the gastrointestinal tract: analysis of 4 cases[J].Nan fang yi ke da xue xue bao = Journal of Southern Medical University.2016,36(9):
APA：
Hu, R.-H,Sun, W.-L,Zhao, H,Hui, W.-H,Guo, Y.-X...&Su, L.(2016).Rituximab combined with EPOCH regimen for treatment of diffuse large B cell lymphoma of the gastrointestinal tract: analysis of 4 cases.Nan fang yi ke da xue xue bao = Journal of Southern Medical University,36,(9)
MLA：
Hu, R.-H,et al."Rituximab combined with EPOCH regimen for treatment of diffuse large B cell lymphoma of the gastrointestinal tract: analysis of 4 cases".Nan fang yi ke da xue xue bao = Journal of Southern Medical University 36..9(2016)
